Physician

Chadi Richeh

According to 2025 Medicare claims, Chadi Richeh (NPI: 1710214218) practices endocrinology in the San Angelo, TX market, with the plurality of this provider's patient population coming from Tom Green, TX. This provider's primary affiliated billing organization is SHANNON CLINIC (NPI: 1770587149; TIN: 752600873) and primary practice location at 76903-5919. Richeh is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Richeh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,047 traditional Medicare patients, billed 4,906 HCPCS/CPT codes, and received $192,121 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 11,850 prescription claims across 1,665 beneficiaries totaling $5,657,676 in drug costs, led by Ozempic (Semaglutide). DME data shows 886 claims. Open Payments data shows 112 records totaling $2,198. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $249,163 to $5,657,676. For DME billing, reported payments moved sharply higher in recent years, from $2,859 to $297,656.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	241	800	$63,704
2016	479	4,751	$163,231
2017	825	10,905	$263,556
2018	917	12,221	$292,635
2019	977	12,821	$286,073
2020	974	11,879	$248,013
2021	1,012	9,002	$242,631
2022	1,013	8,083	$236,157
2023	957	10,902	$246,009
2024	1,047	4,906	$192,121

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	136	1,086	$249,163
2016	353	2,111	$501,716
2017	521	4,048	$1,335,101
2018	727	5,507	$2,396,099
2019	843	6,622	$3,421,600
2020	1,054	7,573	$4,299,140
2021	1,201	8,860	$5,473,992
2022	1,367	9,796	$5,997,550
2023	1,457	10,188	$6,825,357
2024	1,665	11,850	$5,657,676

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	55	134	$2,084
2016	59	115	$5,445
2017	82	221	$7,155
2018	161	488	$47,484
2019	251	743	$88,215
2020	267	919	$129,077
2021	210	1,069	$177,117
2022	223	1,079	$186,385
2023	283	1,381	$261,694
2024	252	886	$300,766

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	154	154	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	863	1,498	$91
83036	Hemoglobin a1c level	371	562	$9
80053	Blood test, comprehensive group of blood chemicals	45	68	$9
36415	Insertion of needle into vein for collection of blood sample	782	1,298	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	740	34,696	$1,073,895
Mounjaro	Tirzepatide	505	19,724	$716,225
Tresiba Flextouch U-100	Insulin Degludec	380	28,092	$420,718
Tresiba Flextouch U-200	Insulin Degludec	150	11,082	$337,005
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	213	14,379	$276,474

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	135	591	$262,546
E0784	External ambulatory infusion pump, insulin	Y	N/R	31	$10,277
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	14	42	$9,585
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	20	$7,997
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	24	24	$5,264

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	112	$2,198	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Chadi Richeh?

Tedicare shows public-source Medicare data for Chadi Richeh (NPI 1710214218), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chadi Richeh have ACO affiliation data?

Chadi Richeh is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Chadi Richeh?

Chadi Richeh is linked to SHANNON CLINIC (billing NPI 1770587149) in the available physician profile data.

Does Chadi Richeh have Open Payments data?

Chadi Richeh has 112 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.